Letrozole Tablet, Film Coated
Product Images NDC 17856-0032

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 17856-0032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Letrozole Label (17856 0032 01)

Letrozole Label (17856 0032 01)
This is a medication package of Letrozole 2.5mg with 100 tablets. The product code is 17856-0032-01 and it includes information on dosage, caution, temperature, TIN, SIN, and expiration date. The medication should be kept out of reach of children and stored within a controlled room temperature. There is also a phone number provided for reordering.*
FDA Label Image

Figure 1 Disease-free Survival (median Follow-up 73 Months, Itt Approach) (Letrozole Fig1)

Figure 1 Disease-free Survival (median Follow-up 73 Months, Itt Approach) (Letrozole Fig1)
FDA Label Image

Figure 2 Kaplan-meier Estimates Of Time To Progression (tamoxifen Study) (Letrozole Fig2)

Figure 2 Kaplan-meier Estimates Of Time To Progression (tamoxifen Study) (Letrozole Fig2)
FDA Label Image

Figure 3 Survival By Randomized Treatment Arm (Letrozole Fig3)

Figure 3 Survival By Randomized Treatment Arm (Letrozole Fig3)
FDA Label Image

Figure 4 Kaplan-meier Estimates Of Time To Progression (megestrol Acetate Study) (Letrozole Fig4)

Figure 4 Kaplan-meier Estimates Of Time To Progression (megestrol Acetate Study) (Letrozole Fig4)
FDA Label Image

Figure 5 Kaplan-meier Estimates Of Time To Progression (aminoglutethimide Study) (Letrozole Fig5)

Figure 5 Kaplan-meier Estimates Of Time To Progression (aminoglutethimide Study) (Letrozole Fig5)
The text appears to be a chart or a graph with headings and values related to a medical treatment group called "Letrozole Tabh." with varying dosages. The chart shows the "TIME TO PROGRESSION (IN DAYS)" for this group, but the contents are unclear as the values do not correctly correspond to the time progression in days. Therefore, a more accurate description cannot be provided.*
FDA Label Image

Letrozole Structural Formula (Letrozole Str)

Letrozole Structural Formula (Letrozole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.